Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Thermogenesis Holdings Inc (THMO)

Thermogenesis Holdings Inc (THMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Thermogenesis Holdings Inc 2711 CITRUS ROAD RANCHO CORDOVA CA 95742 USA

www.thermogenesis.com P: 916-858-5100 F: 916-858-5199

Description:

ThermoGenesis Holdings Inc. develops, commercializes and markets automated technologies for CAR-T and other cell-based therapies. The company markets solutions for automated clinical biobanking, point-of-care applications and automation for immuno-oncology. ThermoGenesis Holdings Inc., formerly known as Cesca Therapeutics Inc., is based in Rancho Cordova, California.

Key Statistics

Overview:

Market Capitalization, $K 5,456
Enterprise Value, $K 3,456
Shares Outstanding, K 7,953
Annual Sales, $ 9,450 K
Annual Net Income, $ -17,980 K
Last Quarter Sales, $ 2,410 K
Last Quarter Net Income, $ -7,010 K
EBIT, $ -6,580 K
EBITDA, $ 2,870 K
60-Month Beta 2.41
% of Insider Shareholders 78.00%
% of Institutional Shareholders 5.78%
Float, K 1,750
% Float 22.00%
Short Volume Ratio 0.47

Growth:

1-Year Return -69.11%
3-Year Return -99.34%
5-Year Return -99.43%
5-Year Revenue Growth -2.28%
5-Year Earnings Growth 100.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.44 on 11/13/23
Latest Earnings Date 05/20/24
Earnings Per Share ttm -6.23
EPS Growth vs. Prev Qtr -58.24%
EPS Growth vs. Prev Year 68.03%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-45 on 12/22/22

THMO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 8.50
Price/Earnings to Growth N/A
Return-on-Equity % -1,001.64%
Return-on-Assets % -113.62%
Profit Margin % -190.26%
Debt/Equity 0.00
Price/Sales 0.61
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.99
Interest Coverage -0.89
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar